Details for New Drug Application (NDA): 021806
✉ Email this page to a colleague
The generic ingredient in VANDAZOLE is metronidazole. There are eighteen drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Summary for 021806
Tradename: | VANDAZOLE |
Applicant: | Teva Pharms |
Ingredient: | metronidazole |
Patents: | 1 |
Suppliers and Packaging for NDA: 021806
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VANDAZOLE | metronidazole | GEL;VAGINAL | 021806 | NDA | Upsher-Smith Laboratories, LLC | 0245-0860 | 0245-0860-70 | 1 TUBE, WITH APPLICATOR in 1 CARTON (0245-0860-70) / 70 g in 1 TUBE, WITH APPLICATOR |
VANDAZOLE | metronidazole | GEL;VAGINAL | 021806 | NDA | RPK Pharmaceuticals, Inc. | 53002-7341 | 53002-7341-1 | 1 TUBE, WITH APPLICATOR in 1 CARTON (53002-7341-1) / 70 g in 1 TUBE, WITH APPLICATOR |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;VAGINAL | Strength | 0.75% | ||||
Approval Date: | May 20, 2005 | TE: | BX | RLD: | No | ||||
Patent: | 7,456,207 | Patent Expiration: | Sep 22, 2024 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 021806
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Teva Pharms | VANDAZOLE | metronidazole | GEL;VAGINAL | 021806-001 | May 20, 2005 | 7,456,207 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription